Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
25.59
-0.68 (-2.59%)
At close: Jan 2, 2026, 4:00 PM EST
25.54
-0.05 (-0.20%)
After-hours: Jan 2, 2026, 4:18 PM EST
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $791.05 million as of January 2, 2026. Its market cap has increased by 32.08% in one year.
Market Cap
791.05M
Enterprise Value
16.71M
1-Year Change
32.08%
Ranking
Category
Stock Price
$25.59
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $791.05M, an increase of 405.46%. That is a compound annual growth rate of 19.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.95B |
| Johnson & Johnson | 498.82B |
| AbbVie | 405.26B |
| UnitedHealth Group | 299.91B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.20B |
| Novo Nordisk | 227.63B |